Test using patient-derived tumor organoids for bile duct cancer
Treatments studied
Part of Cancer clinical trials.
This study uses a lab model made from your tumor (an “organoid”) to predict how well a cancer medicine may work for intrahepatic cholangiocarcinoma (bile duct cancer in the liver). If you join, your eligibility depends mainly on age and having the right tumor biopsy sample available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with intrahepatic cholangiocarcinoma confirmed by tissue tests
- You are between 18 and 80 years old
- You can read, understand, and sign the study consent form
- A biopsy sample from the intrahepatic bile duct tumor is available for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses tumor samples to create lab-grown mini-livers (organoids) to better understand liver cancer. It may help researchers learn more about the disease and develop new treatments.
This trial tests a combination of chemotherapy (gemcitabine and cisplatin) with the targeted therapy lenvatinib and the immunotherapy adebrelimab for people with advanced bile duct cancer that cannot be removed by surgery. It aims to see if this combination works better than standard treatments.
This trial studies whether a liver transplant can help people with a non-removable type of bile duct cancer in the liver. To be eligible, the cancer must be in the liver only (no spread), and you typically must already have had at least 6 months of treatment before being listed for transplant.
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
This trial uses a lab-grown model of your tumor (an organoid) to test which drugs work best before giving them to you. If you cannot have surgery to remove your cancer, this approach may help find a more effective treatment.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
Hear when a new Organoids trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.